Menu

Pharmaceutical Stocks

FTSE 100 Dips as GSK Shares Fall Post-Nuvalent Deal

FTSE Futures Updates

The UK’s blue-chip index, FTSE 100, experienced a decline on Tuesday, primarily influenced by the performance of GSK. This movement followed the healthcare company’s announcement regarding its intention to acquire shares of U.S.-based drug developer Nuvalent for $10.6 billion, a strategic move aimed at enhancing its lung cancer treatment portfolio. The blue-chip FTSE 100 index Read More

FTSE 100 Dips as AstraZeneca Declines

AstraZeneca

The FTSE 100 index saw a downturn following its record high on Tuesday, as declines in AstraZeneca shares and energy stocks overshadowed the gains made by miners. Investors are exercising caution in anticipation of the Bank of England’s policy meeting scheduled for later this week. The blue-chip FTSE 100 index was down 0.2% at 1039 Read More

FtseFutures.org is for Stock Market Information purposes only and is not associated with FTSE Group or LSE.

FtseFutures.org is not a Financial Adviser / Influencer and does not provide any trading or investment skills / tips / recommendations via its website / directly / social media or through any other channel.

Disclaimer / Disclosure and Privacy Policy / Terms and conditions are applicable to all users /members of this website.

The usage of this website means you agree to all of the above